Literature DB >> 24817097

Neurologic complications of diabetes.

Gerald A Charnogursky1, Nicholas V Emanuele, Mary Ann Emanuele.   

Abstract

Neuropathy as a complication of diabetes is common and presents in a wide variety of clinical scenarios. Often the work-up is one of exclusion tempered with monitoring the response of symptoms to treatment options. The collaboration of a neurologist is often crucial to determining the best course of action for the patient. This review will address proposed pathogenic mechanisms and potential therapeutic interventions, both pharmacologic and nonpharmacologic.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24817097     DOI: 10.1007/s11910-014-0457-5

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  145 in total

Review 1.  Painful diabetic neuropathy.

Authors:  S Tesfaye; P Kempler
Journal:  Diabetologia       Date:  2005-05       Impact factor: 10.122

2.  Sural nerve oxygen tension in diabetes.

Authors:  P G Newrick; A J Wilson; J Jakubowski; A J Boulton; J D Ward
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

3.  Progression of diabetic autonomic neuropathy over a decade in insulin-dependent diabetics.

Authors:  M J Sampson; S Wilson; P Karagiannis; M Edmonds; P J Watkins
Journal:  Q J Med       Date:  1990-06

Review 4.  Folates and cardiovascular disease.

Authors:  M C Verhaar; E Stroes; T J Rabelink
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-01       Impact factor: 8.311

5.  Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension.

Authors:  F M Fouad-Tarazi; M Okabe; H Goren
Journal:  Am J Med       Date:  1995-12       Impact factor: 4.965

6.  The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study.

Authors:  P J Dyck; K M Kratz; J L Karnes; W J Litchy; R Klein; J M Pach; D M Wilson; P C O'Brien; L J Melton; F J Service
Journal:  Neurology       Date:  1993-04       Impact factor: 9.910

7.  The natural history of painful diabetic neuropathy--a 4-year study.

Authors:  A J Boulton; W D Armstrong; J H Scarpello; J D Ward
Journal:  Postgrad Med J       Date:  1983-09       Impact factor: 2.401

8.  Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension.

Authors:  B P Grubb; D Samoil; D Kosinski; D Wolfe; M Lorton; E Madu
Journal:  Am J Med       Date:  1994-10       Impact factor: 4.965

9.  Nocturnal oxygen desaturation in diabetic patients with severe autonomic neuropathy.

Authors:  C Neumann; D Martinez; H Schmid
Journal:  Diabetes Res Clin Pract       Date:  1995-05       Impact factor: 5.602

10.  Reduced vascular endothelial growth factor expression and intra-epidermal nerve fiber loss in human diabetic neuropathy.

Authors:  Cristian Quattrini; Maria Jeziorska; Andrew J M Boulton; Rayaz A Malik
Journal:  Diabetes Care       Date:  2007-10-12       Impact factor: 19.112

View more
  5 in total

1.  Protective effect of pregabalin on the brain tissue of diabetic rats.

Authors:  Caner F Demir; Metin Balduz; İrem Taşcı; Tuncay Kuloğlu
Journal:  Diabetol Int       Date:  2020-11-16

Review 2.  Exercise as A Potential Therapeutic Target for Diabetic Cardiomyopathy: Insight into the Underlying Mechanisms.

Authors:  Dae Yun Seo; Jeong Rim Ko; Jung Eun Jang; Tae Nyun Kim; Jae Boum Youm; Hyo-Bum Kwak; Jun Hyun Bae; Amy Hyein Kim; Kyung Soo Ko; Byoung Doo Rhee; Jin Han
Journal:  Int J Mol Sci       Date:  2019-12-12       Impact factor: 5.923

Review 3.  Remote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulceration.

Authors:  J A Epps; N A Smart
Journal:  Cardiovasc Diabetol       Date:  2016-09-09       Impact factor: 9.951

4.  Monocyte-to-high density lipoprotein ratio is associated with a decreased compound muscle action potential amplitude in patients with diabetic axonal polyneuropathy.

Authors:  Gönül Vural; Şadiye Gümüsyayla
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.889

5.  Early disruption of nerve mitochondrial and myelin lipid homeostasis in obesity-induced diabetes.

Authors:  Juan P Palavicini; Juan Chen; Chunyan Wang; Jianing Wang; Chao Qin; Eric Baeuerle; Xinming Wang; Jung A Woo; David E Kang; Nicolas Musi; Jeffrey L Dupree; Xianlin Han
Journal:  JCI Insight       Date:  2020-11-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.